
zzso is a common side effect in elderly patients undergoing zzso zzso and anemia cause considerable zzso may increase zzso and can result in a worse outcome of treatment in elderly patients compared to younger patients with comparable type and stage of zzso The availability and proven efficacy of zzso growth factors such as zzso zzso factor zzso or zzso zzso factor zzso and zzso zzso have had a considerable impact on supportive care in cancer zzso Several zzso trials have demonstrated a reduction of zzso and the frequency of severe infections in elderly patients treated with zzso following zzso chemotherapy compared with patients without growth factor zzso Both for zzso and for zzso human zzso zzso several studies have demonstrated the safety and effectiveness of these molecules in elderly patients with regard to increasing zzso zzso improving quality of life zzso and zzso zzso Although a positive effect of the use of growth factors on overall survival in elderly cancer patients is not yet zzso a reduction of zzso side effects could clearly be zzso The National Comprehensive Cancer Network zzso of cancer centers has recommended that all patients aged 70 years and older treated with zzso or zzso chemotherapy of comparable intensity should receive zzso zzso administration, and that the zzso concentration be maintained at zzso zzso in elderly patients undergoing zzso 

